Starwin sign MoU(1/7/09)MP

THE Centre for Scientific Research into Plant Medicine (CSRPM) at Mampong Akuapem has secured a partnership with Starwin Products Limited (Starwin) to transform its herbal preparations into capsules and tablets.
The transformation of the herbal preparations into capsules and tablets would pave the way for the centre to conveniently dispense and market its products locally and internationally.
An agreement to give effect to the partnership between the centre and Starwin, an orthodox medicine producer, was signed in Accra yesterday.
The Board Chairman of Starwin, Rev Dr Mensa Otabil, and the Managing Director (MD) of Starwin, Mr Kwasi Yirenkyi, signed for Starwin while the Deputy Director of CSRPM, Dr Archibald Sittie, initialled for the centre.
In his remarks, Dr Otabil, who expressed optimism about the success of the collaboration, said the agreement signified the beginning of a major breakthrough in the health delivery system in Ghana.
He said the expression of eagerness and anxiety by the management of both institutions to get the project started, as well as the enormous potential those institutions possessed, made him optimistic about the success of the project.
He said Starwin could boast highly skilled and dedicated manpower and modern machinery and equipment that could meet the challenges of the project.
He said the selected malaria, typhoid, arthritis, diabetes and hypertension drugs were already in reasonable demand, even in their raw form, adding that there was no doubt that as the products got to their finished forms, demand for them would increase tremendously.
That, Dr Otabil said, would lead to increase in the operation capacity of Starwin and increase in turnover, adding, "In the end, our shareholders and indeed Ghana as a whole will benefit."
He expressed his desire for the management of the institutions to work hard to bring the project into fruition in the quickest possible time.
The MD of Starwin said the collaboration would be of enormous benefit to the whole country in the delivery of quality health care.
He said the agreement was an indication that Starwin was going to increase its line of products to increase revenue for its shareholders and the country as a whole.
The Deputy Director of CSRPM, Dr Archibald Sittie, said this was the opportunity for traditional medicine to break boundaries and gain recognition and market internationally.
He said revenue generated would help the centre widen its research agenda and produce more herbal medicines to be transformed into tablets and capsules to complement the health delivery system in the country.